Hybrid Polymeric Tissue Scaffold for Elastin Network Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tissue engineering approaches face challenges in replicating the mechanical properties and biocompatibility of elastin in tissue scaffolds, particularly for applications like tissue-engineered blood vessels, where incompatibility can lead to graft failure and complications such as aneurysm and intimal hyperplasia.
Innovation Solution
A hybrid polymeric material comprising tropoelastin and a copolymer of a polyol monomer and a polycarboxylic acid, specifically poly(glycerol sebacate), is developed, which promotes elastin network formation, offering suitable mechanical and structural properties for tissue regeneration, including improved endothelialization and reduced intimal hyperplasia.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If synthetic implants are used to repair or replace damaged tissue, then mechanical durability is improved, but tissue compatibility and functional integration deteriorate
Solution Approach 1:
The patent employs composite materials by combining synthetic polymeric materials with natural elastin or elastin-derived peptides. This composite approach allows the scaffold to exhibit both the mechanical durability of synthetic materials and the biological compatibility of natural elastin, resolving the contradiction between longevity and tissue acceptance.
Solution Approach 2:
The patent modifies physical and chemical parameters of the polymeric materials, including degradation rate, elasticity modulus, and surface properties, to match native tissue characteristics. By tuning these parameters, the scaffold achieves optimal balance between mechanical strength and biological functionality.
2Reliability
If elastin content is increased to improve mechanical compliance matching, then tissue compatibility is improved, but structural stability and durability deteriorate
Solution Approach 1:
The scaffold uses composite construction where elastin or elastin-derived peptides provide biological compatibility and compliance matching, while the synthetic polymeric matrix provides structural stability and mechanical strength. This division of functional roles resolves the contradiction between softness and strength.
Solution Approach 2:
The patent applies different material properties to different regions or aspects of the scaffold. Elastin-rich regions provide compliance and biological functionality, while synthetic polymer regions provide structural support, creating local optimization of properties throughout the scaffold structure.
3Reliability
If natural elastin is used to improve biocompatibility, then tissue integration is improved, but mechanical strength and durability deteriorate
Solution Approach 1:
The patent creates composite scaffolds where natural elastin or elastin peptides are integrated with durable synthetic polymeric materials. The natural elastin components provide biocompatibility and promote tissue integration, while the synthetic matrix ensures long-term mechanical durability and structural integrity.
Solution Approach 2:
Elastin-derived peptides and fragments act as intermediary components that bridge the gap between synthetic materials and native tissue. These intermediaries provide biological functionality and compatibility while being incorporated into the synthetic polymer matrix, enabling long-term durability.
Data Source
AI summary
Disclosed herein is a hybrid polymeric material comprising a tropoelastin and a copolymer of a polyol monomer and a polycarboxylic acid monomer. The hybrid polymeric material is suitable for use as a tissue scaffold.